For context, Tempus uses AI to improve precision medicine solutions, as well as drug discovery and diagnostics. Its operating ...

Tempus AI (TEM) announced that ten abstracts have been accepted for presentation at the 2025 American Society of Clinical Oncology, ASCO, Annual Meeting. The event will take place May 30 – June 3 in ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tempus AI, Inc. resulting from allegations that Tempus AI ...

E.L.F. Beauty’s stock is up more than 34% in the last week. The positive performance, primarily driven by an over 23% surge ...

An independent safety board has endorsed the continuation of BioXcel Therapeutics, Inc.'s (NASDAQ: BTAI) pivotal Phase 3 SERENITY At-Home trial evaluating BXCL501 for agitation tied to bipolar ...

The act would require all therapy services be conducted by a licensed professional, prohibiting AI from providing direct patient care.